A new approach to refractory gastrointestinal stromal tumours with diverse acquired mutations

Lancet Oncol. 2020 Jul;21(7):864-865. doi: 10.1016/S1470-2045(20)30209-6. Epub 2020 Jun 5.

Authors

Toshirou Nishida¹, Toshihiko Doi²

Affiliations

¹ Department of Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan. Electronic address: tnishida@ncc.go.jp.
² Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan.

PMID: 32511982
DOI: 10.1016/S1470-2045(20)30209-6

No abstract available

Publication types

Comment

MeSH terms

Double-Blind Method
Gastrointestinal Neoplasms*
Gastrointestinal Stromal Tumors*
Humans
Mutation